Spero Therapeutics (SPRO) Cash & Equivalents (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.40% |
| Dec 31, 2025 | -17.18% |
| Sep 30, 2025 | 55.85% |
| Jun 30, 2025 | -36.19% |
| Mar 31, 2025 | -7.57% |
| Dec 31, 2024 | -30.67% |
| Sep 30, 2024 | 20.09% |
| Jun 30, 2024 | -22.78% |
| Mar 31, 2024 | 7.78% |
| Dec 31, 2023 | -18.64% |
| Sep 30, 2023 | 20.77% |
| Jun 30, 2023 | -19.29% |
| Mar 31, 2023 | -11.78% |
| Dec 31, 2022 | 116.28% |
| Sep 30, 2022 | 11.11% |
| Jun 30, 2022 | -37.04% |
| Mar 31, 2022 | -35.95% |
| Dec 31, 2021 | -0.24% |
| Sep 30, 2021 | 57.71% |
| Jun 30, 2021 | -7.11% |
| Mar 31, 2021 | -9.58% |
| Dec 31, 2020 | -31.96% |
| Sep 30, 2020 | 91.67% |
| Jun 30, 2020 | 1.52% |
| Mar 31, 2020 | 116.49% |
| Dec 31, 2019 | -34.80% |
| Sep 30, 2019 | -35.90% |
| Jun 30, 2019 | 44.01% |
| Mar 31, 2019 | 44.94% |
| Dec 31, 2018 | -15.81% |
| Sep 30, 2018 | -16.90% |
| Jun 30, 2018 | -7.30% |
| Mar 31, 2018 | -39.79% |
| Dec 31, 2017 | 244.02% |
| Dec 31, 2016 | -8.55% |